Shares of Tarsons Products Ltd. tumbled the most since debut after its first-quarter profit dropped and margin contracted.
X
Shares of the company fell as much as 20%, the most since Nov. 26, before closing 9.7% lower on Monday. The stock is also the worst performer on the S&P BSE IPO and S&P BSE Healthcare indices.
All the three analysts tracking the company reiterated a 'buy'. The 12-month consensus price target implies an upside of 17.5%.
WRITTEN BY
ADVERTISEMENT